Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

POINT Biopharma Global Inc. (PNT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-K10-K
Revenues  226.60.00.0
Cost of goods sold  0.00.00.0
Gross profit  226.60.00.0
            Gross margin  100.0%  
Selling, general and administrative   [+]19.012.04.0
Research and development  82.133.59.1
EBITDA   [+]126.9  
            EBITDA margin  56.0%  
Depreciation and amortization  1.4  
EBIT   [+]125.5-45.5-13.1
            EBIT margin  55.4%  
Interest income, net   [+]4.50.00.0
Other income (expense), net   [+]-0.4-0.1-0.2
Pre-tax income  129.6-45.6-13.3
Income taxes  31.30.30.1
            Tax rate  24.1%  
Net income  98.3-45.9-13.4
            Net margin  43.4%  
   
Basic EPS   [+]$1.04($0.62)($0.34)
Diluted EPS   [+]$1.02($0.62)($0.34)
   
Shares outstanding (basic)   [+]94.673.938.9
Shares outstanding (diluted)   [+]96.073.938.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy